Literature DB >> 15184152

Specific 12 beta-hydroxylation of cinobufagin by filamentous fungi.

Min Ye1, Guiqin Qu, Hongzhu Guo, Dean Guo.   

Abstract

Biotransformation of natural products has great potential for producing new drugs and could provide in vitro models of mammalian metabolism. Microbial transformation of the cytotoxic steroid cinobufagin was investigated. Cinobufagin could be specifically hydroxylated at the 12 beta-position by the fungus Alternaria alternata. Six products from a scaled-up fermentation were obtained by silica gel column chromatography and reversed-phase liquid chromatography and were identified as 12 beta-hydroxyl cinobufagin, 12 beta-hydroxyl desacetylcinobufagin, 3-oxo-12 beta-hydroxyl cinobufagin, 3-oxo-12 beta-hydroxyl desacetylcinobufagin, 12-oxo-cinobufagin, and 3-oxo-12 alpha-hydroxyl cinobufagin. The last five products are new compounds. 12 beta-Hydroxylation of cinobufagin by A. alternata is a fast catalytic reaction and was complete within 8 h of growth with the substrate. This reaction was followed by dehydrogenation of the 3-hydroxyl group and then deacetylation at C-16. Hydroxylation at C-12 beta also was the first step in the metabolism of cinobufagin by a variety of fungal strains. In vitro cytotoxicity assays suggest that 12 beta-hydroxyl cinobufagin and 3-oxo-12 alpha-hydroxyl cinobufagin exhibit somewhat decreased but still significant cytotoxic activities. The 12 beta-hydroxylated bufadienolides produced by microbial transformation are difficult to obtain by chemical synthesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184152      PMCID: PMC427727          DOI: 10.1128/AEM.70.6.3521-3527.2004

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  24 in total

Review 1.  Biocatalytic modification of natural products.

Authors:  S Riva
Journal:  Curr Opin Chem Biol       Date:  2001-04       Impact factor: 8.822

Review 2.  Protein engineering of oxygenases for biocatalysis.

Authors:  Patrick C Cirino; Frances H Arnold
Journal:  Curr Opin Chem Biol       Date:  2002-04       Impact factor: 8.822

Review 3.  Microbial models of mammalian metabolism of xenobiotics: An updated review.

Authors:  E A Abourashed; A M Clark; C D Hufford
Journal:  Curr Med Chem       Date:  1999-05       Impact factor: 4.530

4.  QSAR evaluation of the Ch'an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/5(1).

Authors:  Yoshiaki Kamano; Ayano Yamashita; Toshihiko Nogawa; Hiroshi Morita; Koichi Takeya; Hideji Itokawa; Toshiaki Segawa; Ayako Yukita; Kyoko Saito; Mariko Katsuyama; George R Pettit
Journal:  J Med Chem       Date:  2002-12-05       Impact factor: 7.446

Review 5.  Biotransformations using prokaryotic P450 monooxygenases.

Authors:  Vlada Urlacher; Rolf D Schmid
Journal:  Curr Opin Biotechnol       Date:  2002-12       Impact factor: 9.740

6.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

Authors:  J Carmichael; W G DeGraff; A F Gazdar; J D Minna; J B Mitchell
Journal:  Cancer Res       Date:  1987-02-15       Impact factor: 12.701

7.  [255. Additional bufadienolides from Ch'an Su. Toad venoms. 39].

Authors:  N Höriger; D Zivanov; H H Linde; K Meyer
Journal:  Helv Chim Acta       Date:  1972       Impact factor: 2.164

8.  Biotransformations of the cardiovascular drugs mexrenone and canrenone.

Authors:  Carol L Preisig; Jodi A Laakso; Ursula M Mocek; Ping T Wang; Julio Baez; Graham Byng
Journal:  J Nat Prod       Date:  2003-03       Impact factor: 4.050

9.  Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells.

Authors:  Jiun-Yih Yeh; William J Huang; Shu-Fen Kan; Paulus S Wang
Journal:  Prostate       Date:  2003-02-01       Impact factor: 4.104

10.  Bufalin as a potent inducer of differentiation of human myeloid leukemia cells.

Authors:  L S Zhang; K Nakaya; T Yoshida; Y Kuroiwa
Journal:  Biochem Biophys Res Commun       Date:  1991-07-31       Impact factor: 3.575

View more
  7 in total

1.  Biotransformation of Meloxicam by Cunninghamella blakesleeana: Significance of Carbon and Nitrogen Source.

Authors:  Gurram Shyam Prasad; Kollu Narasimha Rao; Rama Preethi; Sivasri Girisham; S M Reddy
Journal:  Indian J Microbiol       Date:  2011-01-30       Impact factor: 2.461

2.  Formation of glucoside conjugate of acetaminophen by fungi separated from soil.

Authors:  H H Huang; L H Lin; P Zhang; X L Qi; D F Zhong
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Apr-Jun       Impact factor: 2.441

3.  Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma.

Authors:  Tian-Jie Qin; Xin-Han Zhao; Jun Yun; Ling-Xiao Zhang; Zhi-Ping Ruan; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

4.  Fungal transformation of androsta-1,4-diene-3,17-dione by Aspergillus brasiliensis.

Authors:  Tahereh Hosseinabadi; Hossein Vahidi; Bahman Nickavar; Farzad Kobarfard
Journal:  Daru       Date:  2014-11-15       Impact factor: 3.117

Review 5.  In vitro strategies for the enhancement of secondary metabolite production in plants: a review.

Authors:  Mohammad Afaan Fazili; Irfan Bashir; Mudasar Ahmad; Ubaid Yaqoob; Syed Naseem Geelani
Journal:  Bull Natl Res Cent       Date:  2022-02-19

Review 6.  Chemistry and the Potential Antiviral, Anticancer, and Anti-Inflammatory Activities of Cardiotonic Steroids Derived from Toads.

Authors:  Hesham R El-Seedi; Nermeen Yosri; Bishoy El-Aarag; Shaymaa H Mahmoud; Ahmed Zayed; Ming Du; Aamer Saeed; Syed G Musharraf; Islam M El-Garawani; Mohamed R Habib; Haroon Elrasheid Tahir; Momtaz M Hegab; Xiaobo Zou; Zhiming Guo; Thomas Efferth; Shaden A M Khalifa
Journal:  Molecules       Date:  2022-10-05       Impact factor: 4.927

7.  Cinobufacini promotes apoptosis of bladder cancer cells by influencing the expression of autophagy-related genes.

Authors:  Dong Chen; Junyi Chen; Yihong Guo; Yining Li
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.